Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

pfizer italia s.r.l. - idarubicina clorhidrato - idarubicina clorhidrato....5mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

pfizer australia pty ltd - idarubicina clorhidrato - idarubicina clorhidrato....1 mg.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, solution - excipient ingredients: glycerol; hydrochloric acid; water for injections - zavedos is indicated for use in acute myelogenous leukaemia (aml) in adults for remission induction in untreated patients or for remission induction in relapsed or refractory patients. zavedos capsules are indicated whenever the intravenous route is not considered suitable. zavedos may be used in combination chemotherapy regimens involving other cytotoxic agents.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, solution - excipient ingredients: glycerol; hydrochloric acid; water for injections - zavedos is indicated for use in acute myelogenous leukaemia (aml) in adults for remission induction in untreated patients or for remission induction in relapsed or refractory patients. zavedos capsules are indicated whenever the intravenous route is not considered suitable. zavedos may be used in combination chemotherapy regimens involving other cytotoxic agents.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - idarubicin hydrochloride 10mg; idarubicin hydrochloride 10mg; idarubicin hydrochloride 10mg - capsule - 10 mg - active: idarubicin hydrochloride 10mg excipient: gelatin glyceryl palmito-stearate iron oxide red microcrystalline cellulose opacode black s-1-27794 titanium dioxide active: idarubicin hydrochloride 10mg excipient: gelatin glyceryl palmito-stearate iron oxide red microcrystalline cellulose titanium dioxide active: idarubicin hydrochloride 10mg excipient: gelatin glyceryl palmito-stearate iron oxide red microcrystalline cellulose tekprint black sw-9008 titanium dioxide - zavedos is an antimitotic and cytotoxic agent. it is indicated for use in acute myelogenous leukaemia (aml), in adults for remission induction in untreated patients, or for remission induction in relapsed or refractory patients. zavedos capsules are indicated whenever the intravenous route is not considered suitable. zavedos is also an effective agent for use in the second line treatment of advanced breast cancer either as a single agent or in a combination regimen.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - idarubicin hydrochloride 25mg; idarubicin hydrochloride 25mg; idarubicin hydrochloride 25mg - capsule - 25 mg - active: idarubicin hydrochloride 25mg excipient: gelatin glyceryl palmito-stearate microcrystalline cellulose opacode black s-1-27794 titanium dioxide active: idarubicin hydrochloride 25mg excipient: gelatin glyceryl palmito-stearate microcrystalline cellulose titanium dioxide active: idarubicin hydrochloride 25mg excipient: gelatin glyceryl palmito-stearate microcrystalline cellulose tekprint black sw-9008 titanium dioxide - zavedos is an antimitotic and cytotoxic agent. it is indicated for use in acute myelogenous leukaemia (aml), in adults for remission induction in untreated patients, or for remission induction in relapsed or refractory patients. zavedos capsules are indicated whenever the intravenous route is not considered suitable. zavedos is also an effective agent for use in the second line treatment of advanced breast cancer either as a single agent or in a combination regimen.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - idarubicin hydrochloride 5mg; idarubicin hydrochloride 5mg; idarubicin hydrochloride 5mg - capsule - 5 mg - active: idarubicin hydrochloride 5mg excipient: gelatin glyceryl palmito-stearate iron oxide red microcrystalline cellulose opacode black s-1-27794 titanium dioxide active: idarubicin hydrochloride 5mg excipient: gelatin glyceryl palmito-stearate iron oxide red microcrystalline cellulose titanium dioxide active: idarubicin hydrochloride 5mg excipient: gelatin glyceryl palmito-stearate iron oxide red microcrystalline cellulose tekprint black sw-9008 titanium dioxide - zavedos is an antimitotic and cytotoxic agent. it is indicated for use in acute myelogenous leukaemia (aml), in adults for remission induction in untreated patients, or for remission induction in relapsed or refractory patients. zavedos capsules are indicated whenever the intravenous route is not considered suitable. zavedos is also an effective agent for use in the second line treatment of advanced breast cancer either as a single agent or in a combination regimen.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - idarubicin hydrochloride - powder for concentrate for solution for infusion - idarubicin hydrochloride 10 mg/vial - idarubicin - idarubicin - antimitotic and cytotoxic agent. acute non-limphocytic leukemia (anll) in adults for remission induction in untreated patients or for remission induction in relapsed or refractory patients.acute limphocytic leukemia (all) as second line treatment in adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - idarubicin hydrochloride -

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - idarubicin hcl - injection - 10 mg/10 ml - idarubicin hcl 10 mg/10 ml